[ad_1]
MANILA, Philippines – Sinovac Biotech may begin late-stage testing of its coronavirus vaccine in the Philippines next month, the head of the food and drug agency said Thursday, after passing the initial stage of the country’s screening process. .
The Food and Drug Administration (FDA) expects to receive the Chinese drugmaker’s formal application for phase three clinical trials within two weeks and regulators will make a decision after their evaluation, said FDA Director Rolando Enrique Sunday.
Domingo told reporters that the start of the test in November was “possible.”
Philippine President Rodrigo Duterte repeated on Wednesday that he preferred his country to obtain its COVID-19 vaccines from China or Russia.
He also said he wanted the entire population to be vaccinated and had previously said he would not reopen schools until a vaccine is available.
A spokesperson for Sinovac confirmed that materials had been provided to the Philippines in hopes of starting Phase 3 testing, but did not give a deadline.
Jaime Montoya, a member of a panel of experts examining applications for clinical trials and drugs, told Reuters that a technical evaluation of Sinovac had been completed and the results had already been submitted to an ethics board for review.
The Philippines is also evaluating COVID-19 vaccines from Russia’s Gamaleya Research Institute and Johnson & Johnson’s Janssen for late-stage trials and is speaking with US drug maker Pfizer Inc and Moderna Inc as potential suppliers. The Southeast Asian nation has 346,536 confirmed COVID-19, the highest in the region, and 6,449 deaths.
JPV
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our leaders in healthcare and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]